Literature DB >> 32866248

Ten Reasons to Think about Bile Acids in Managing Inflammatory Bowel Disease.

Michael Camilleri1.   

Abstract

Entities:  

Keywords:  barrier; chenodeoxycholic; cholic; deoxycholic; hepatic; lithocholic; mucus

Year:  2020        PMID: 32866248      PMCID: PMC7944489          DOI: 10.1093/ecco-jcc/jjaa175

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  45 in total

1.  Ursodeoxycholic Acid Inhibits Clostridium difficile Spore Germination and Vegetative Growth, and Prevents the Recurrence of Ileal Pouchitis Associated With the Infection.

Authors:  Alexa R Weingarden; Chi Chen; Ningning Zhang; Carolyn T Graiziger; Peter I Dosa; Clifford J Steer; Megan K Shaughnessy; James R Johnson; Michael J Sadowsky; Alexander Khoruts
Journal:  J Clin Gastroenterol       Date:  2016-09       Impact factor: 3.062

2.  Combined Fasting Serum C4 and Primary Bile Acids From a Single Stool Sample to Diagnose Bile Acid Diarrhea.

Authors:  Priya Vijayvargiya; Michael Camilleri; Ann Taylor; Irene Busciglio; Edward V Loftus; Leslie J Donato
Journal:  Gastroenterology       Date:  2020-07-06       Impact factor: 22.682

Review 3.  Neuro-humoral signalling by bile acids and the TGR5 receptor in the gastrointestinal tract.

Authors:  Nigel W Bunnett
Journal:  J Physiol       Date:  2014-03-10       Impact factor: 5.182

4.  Fecal Microbiota Transplantation for Dysbiosis - Predictable Risks.

Authors:  Martin J Blaser
Journal:  N Engl J Med       Date:  2019-10-30       Impact factor: 91.245

5.  Detection of Gut Dysbiosis due to Reduced Clostridium Subcluster XIVa Using the Fecal or Serum Bile Acid Profile.

Authors:  Masashi Murakami; Junichi Iwamoto; Akira Honda; Takeshi Tsuji; Makoto Tamamushi; Hajime Ueda; Tadakuni Monma; Naoki Konishi; Shoichiro Yara; Takeshi Hirayama; Teruo Miyazaki; Yoshifumi Saito; Tadashi Ikegami; Yasushi Matsuzaki
Journal:  Inflamm Bowel Dis       Date:  2018-04-23       Impact factor: 5.325

6.  Bile acids and colonic motility in the rabbit and the human.

Authors:  W O Kirwan; A N Smith; W D Mitchell; J D Falconer; M A Eastwood
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

7.  Diarrhea in Crohn’s disease: investigating the role of the ileal hormone fibroblast growth factor 19.

Authors:  Jonathan D Nolan; Ian M Johnston; Sanjeev S Pattni; Tracy Dew; Timothy R Orchard; Julian R F Walters
Journal:  J Crohns Colitis       Date:  2015-02       Impact factor: 9.071

8.  A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification.

Authors:  Simrat P S Saini; Junichiro Sonoda; Li Xu; David Toma; Hirdesh Uppal; Ying Mu; Songrong Ren; David D Moore; Ronald M Evans; Wen Xie
Journal:  Mol Pharmacol       Date:  2004-02       Impact factor: 4.436

9.  Bile acid malabsorption deactivates pregnane X receptor in patients with Crohn's disease.

Authors:  Junichi Iwamoto; Yoshifumi Saito; Akira Honda; Teruo Miyazaki; Tadashi Ikegami; Yasushi Matsuzaki
Journal:  Inflamm Bowel Dis       Date:  2013-05       Impact factor: 5.325

10.  Detoxification of lithocholic acid. Elucidation of the pathways of oxidative metabolism in rat liver microsomes.

Authors:  P Zimniak; E J Holsztynska; R Lester; D J Waxman; A Radominska
Journal:  J Lipid Res       Date:  1989-06       Impact factor: 5.922

View more
  1 in total

Review 1.  Bile Acids and the Microbiome: Making Sense of This Dynamic Relationship in Their Role and Management in Crohn's Disease.

Authors:  Aditi Kumar; Hafid O Al-Hassi; Helen Steed; Oliver Phipps; Matthew J Brookes
Journal:  Can J Gastroenterol Hepatol       Date:  2022-03-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.